The modern enthusiasm surrounding biomarker testing and preventive diagnostics reflects a growing conviction that disease can be intercepted long before...
Read moreTestosterone replacement therapy and broader hormone optimization have migrated from endocrinology clinics into subscription platforms, influencer podcasts, and venture-backed telehealth...
Read moreThe gut-brain axis—once a niche topic in neurogastroenterology and mucosal immunology—is now a staple of TikTok explainers and supplement...
Read moreThe United States fertility rate has declined to historic lows, falling below replacement level for more than a decade. According...
Read moreAttention-deficit/hyperactivity disorder has moved from the margins of pediatric psychiatry into the center of educational policy and pharmaceutical logistics. Over...
Read moreHealthy aging has emerged as one of the most persistently discussed healthcare themes across clinical conferences, investment forums, and consumer...
Read moreAcross health systems, Medicaid waivers, and employer-sponsored benefit designs, “food as medicine” initiatives are moving from demonstration projects to embedded...
Read moreBreathwork seminars sell out in corporate conference rooms. Cold plunge tubs now sit beside Pelotons in executive homes. “Regulating the...
Read moreEmergency and seasonal preparedness for influenza, respiratory syncytial virus, and COVID has become a standing agenda item for hospital executives,...
Read moreTelehealth expansion, virtual intensive care units, and remote neonatal and specialty nursing programs have moved from pilot status to operating...
Read moreThe wellness industry did not wait for healthcare reform; it built a parallel operating system and invited the public to...
Read moreThe most influential dermatology consultation of the decade may be happening between a teenager and a front-facing camera. Search and...
Read moreGlucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy